Enhanced antibody response to rabies virus in patients with neurologic complications following brain tissue-derived rabies vaccination

T. Hemachudha, P. Khawplod, P. Phanuphak, D. E. Griffin

Research output: Contribution to journalArticle

Abstract

Sera from 26 patients with major neurologic complications, 19 patients with minor complications and 23 patients with no complications induced by Semple rabies vaccine were assayed for neutralizing antibody to rabies virus. Seroconversion to the protective level (≥ 0.5 IU/ml) was found in 21 of 22 patients (95%) with major complications, and in 7 of 19 (37%) with minor complications, occurring during the first 14 days of vaccination. This was in contrast to 42% (5/12) seroconversion in uncomplicated recipients after 14 daily injections. After initiation of dexamethasone treatment, 13 of 18 patients with major complications showed a diminution in their rabies antibody levels on day 4 or 7.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalAsian Pacific Journal of Allergy and Immunology
Volume7
Issue number1
StatePublished - Jan 1 1989
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Enhanced antibody response to rabies virus in patients with neurologic complications following brain tissue-derived rabies vaccination'. Together they form a unique fingerprint.

  • Cite this